Effect of Ozone Treatment on Airway Reactivity and Epithelium-Derived Relaxing Factor in Guinea Pigs
Public Domain
-
2000/06/01
-
Details
-
Personal Author:Cutler D ; Dey RD ; Dortch-Carnes J ; Fedan, Jeffery S. ; Frazer DG ; Goldsmith WT ; Hubbs A ; Johnston RA ; Millecchia LL ; Orsini L ; Rengasamy A ; Reynolds JS ; Watson D ; Yuan LX
-
Description:Ozone (O(3)) is toxic to respiratory epithelium and causes airway inflammation and hyperreactivity. To evaluate the role of the epithelium in the development of hyperreactivity, we examined in guinea pigs the effects of inhaled O(3) (3 ppm for 1 h; 0-24 h after exposure) on 1) reactivity to inhaled methacholine (MCh), 2) reactivity of the isolated, perfused trachea (IPT) to MCh, 3) epithelium-derived relaxing factor (EpDRF)-mediated relaxations of IPT induced by mucosal hyperosmolar solutions, 4) neurogenic contraction and relaxation responses, 5) transepithelial potential difference, and 6) microscopic analysis of nitrotyrosine immunofluorescence, substance P fiber density, and tracheal morphology. At 0 h, O(3) caused hyperreactivity to inhaled MCh and mucosally but not serosally applied MCh in IPT (only in the presence of the epithelium) and a decrease in transepithelial potential difference. Inhibition of EpDRF-induced relaxation responses occurred at 2 h. All of these changes returned to control by 12 to 18 h. O(3) had no effect on neurogenic responses. Nitrotyrosine immunofluorescence appeared in the trachea at 0 h in detached epithelial cell ghosts and in intrapulmonary airways by 6 h. Substance P fiber density was elevated in smooth muscle at 0 and 18 h but not in epithelium or lamina propria of intrapulmonary and extrapulmonary bronchi. Loss of cilia and mucosubstances in the mucosa occurred at 0 h; the epithelium became markedly attenuated over 12 to 24 h. A reversible increase in epithelial permeability and a decrease in EpDRF production may contribute to O(3)-induced hyperreactivity to MCh. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0022-3565
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Volume:293
-
Issue:3
-
NIOSHTIC Number:nn:20020666
-
Citation:J Pharmacol Exp Ther 2000 Jun; 293(3):724-734
-
Email:jsf2@cdc.gov
-
CAS Registry Number:
-
Federal Fiscal Year:2000
-
Peer Reviewed:True
-
Source Full Name:Journal of Pharmacology and Experimental Therapeutics
-
Collection(s):
-
Main Document Checksum:urn:sha-512:95f684e27f262aeb912109569dc74e9ee138c7590db3314321a11a50c2d3b63f1a866424c58df0dc09f4f2f44a53749107b95fef0af4984c5ae5f04b122a6dc6
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like